Verde Resources has developed a novel approach to integrate biochar into asphalt, creating roads that act as long-term carbon storage assets and generate verified carbon removal credits. This innovation leverages existing infrastructure projects to help meet global decarbonization goals without requiring new sustainability spending. Verde has secured key partnerships, including a 10-year commercialization deal with Ergon Asphalt & Emulsions and a strategic collaboration in Singapore, aiming to scale this technology globally. The company also achieved independent environmental verification, positioning itself to benefit from growing demand in both voluntary and compliance carbon markets, such as the upcoming CORSIA aviation scheme.
Verde Resources' innovation in turning roads into carbon assets provides context for the Basic Materials sector's market activity. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 19, 2026 21:32 WIB: out of 83 priced US stocks, 25 rose and 54 fell. Notable movers include ASPN at USD 5.29 (+1.93%, typical hold time 14 days), CLMT at USD 56.66 (-1.89%, typical hold time 4 days), and SOLS at USD 60.30 (+1.77%, typical hold time 4 days).
Miracles, a personalized children's book maker, has printed more than 100,000 books, serving over 45,000 families. Each book features a unique 3D character of the child, created from a single photo, making the child the hero of the story. Books for U...
Miracles, a company specializing in personalized children's books where each child becomes the story's hero, has printed over 100,000 books for more than 45,000 families. The books are printed locally in Germany and delivered within a few days, offer...
The global migraine market is projected to expand at a 6% annual growth rate through 2036, driven by rising migraine prevalence, better diagnosis, and awareness. Innovative treatments beyond traditional CGRP inhibitors, including PACAP-targeted thera...
Disc Medicine's stock surged 38% following positive Phase 3 trial results for its drug bitopertin, which showed efficacy and safety in treating erythropoietic protoporphyria. BMO Capital raised its price target from $100 to $120 and maintained an Out...
Qualcomm executive Ann C. Chaplin sold 1,827 shares of the company's stock for $319,268.25 under a Rule 10b5-1 trading plan, reducing her holdings by 6.62%. Qualcomm's stock price recently traded below its 50-day and 200-day moving averages, signalin...
